Drug
ETD001 clinical trials
Keep track of what changes. Save the ETD001 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- ETD001
- 1
Studies by the year they started
2 studies that test it; most in 2021 (1); 1 more planned to start later
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Enterprise Therapeutics Ltd (2) · Etern Therapeutics Wuxi Limited (1)
Studies
Open first, then newest update. How each study uses ETD001 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Phase II Clinical Study on Preliminary Efficacy and Safety of ETD-001 Gel for Hypertrophic ScarsNot yet recruitingPhase 2Etern Therapeutics Wuxi LimitedNCT07891416Written as ETD-001 gel
- A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic FibrosisCompletedPhase 2Enterprise Therapeutics LtdNCT06478706Written as ETD001
- A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy SubjectsCompletedPhase 1Enterprise Therapeutics LtdNCT04926701Written as ETD001 single dose